Stimcell Energetics (STME) Cash & Equivalents Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -36.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.99% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.52% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.25% |
| 10 | Stimcell Energetics | - | - | - | 10.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 10.37% |
| Nov 30, 2025 | 37.35% |
| Aug 31, 2025 | -12.53% |
| May 31, 2025 | -15.75% |
| Feb 28, 2025 | -39.88% |
| Nov 30, 2024 | -3.08% |
| Aug 31, 2024 | -31.44% |
| May 31, 2024 | 27.89% |
| Feb 29, 2024 | 45.31% |
| Nov 30, 2023 | 1.27% |
| Aug 31, 2023 | -21.59% |
| May 31, 2023 | 29.66% |
| Feb 28, 2023 | -59.29% |
| Nov 30, 2022 | -59.84% |
| Aug 31, 2022 | -69.90% |
| May 31, 2022 | -24.73% |
| Feb 28, 2022 | -38.30% |
| Nov 30, 2021 | 15.08% |
| Aug 31, 2021 | 67.04% |
| May 31, 2021 | 36.28% |
| Feb 28, 2021 | 2.59% |
| Nov 30, 2020 | -41.42% |
| Aug 31, 2020 | -28.24% |
| May 31, 2020 | -12.58% |
| Feb 29, 2020 | 131.27% |
| Nov 30, 2019 | 32.59% |
| Aug 31, 2019 | 110.23% |
| May 31, 2019 | 27.54% |
| Feb 28, 2019 | 106.81% |
| May 31, 2017 | 283.04% |
| May 31, 2016 | 35.91% |
| May 31, 2014 | 313.39% |